KHAITAN CHEMICALS & FERTILIZERS
|
|
BOM : 507794     NSE : KHAICHEM     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Apr 17,2025 |
Price(EOD): ₹ 51.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Fertilizers |
MCap: ₹ 501.01 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
KHAITAN CHEMICALS & FERTILIZERS | 8.8% | 5.7% | -31.5% |
COROMANDEL INTERNATIONAL | 5.6% | 17.9% | 84.8% |
THE FERTILISERS AND CHEMICALS TRAVANCORE | 27.6% | 26.9% | -1.4% |
CHAMBAL FERTILISERS AND CHEMICALS | 5.6% | 21.1% | 75.4% |
DEEPAK FERTILISERS AND PETROCHEMICALS CORPORATION | 11.7% | 15.7% | 128.3% |
GUJARAT NARMADA VALLEY FERTILIZERS & CHEMICALS | 6.4% | 5.1% | -29% |
PARADEEP PHOSPHATES | 16.4% | 46.2% | 90.8% |
GUJARAT STATE FERTILIZERS & CHEMICALS | 12.1% | 12.5% | -20.5% |
RASHTRIYA CHEMICALS AND FERTILIZERS | 15.2% | 19.8% | -7.7% |
FUNDAMENTAL ANALYSIS OF KHAITAN CHEMICALS & FERTILIZERS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF KHAITAN CHEMICALS & FERTILIZERS
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
-11.22
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -44.64 Cr
[Latest Qtr - Dec2024 - Standalone Results ] 2.27
P/B Calculated based on Book Value of Rs 220.49 Cr
[Latest Year - Mar2024 - Standalone Results ] 0.82
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 149% 156% |
SHARE PRICE MOMENTUM OF KHAITAN CHEMICALS & FERTILIZERS
KHAITAN CHEMICALS & FERTILIZERS vs SENSEX
DEBT OF KHAITAN CHEMICALS & FERTILIZERS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
1.4 0.75 0.54 0.9 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF KHAITAN CHEMICALS & FERTILIZERS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2025 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF KHAITAN CHEMICALS & FERTILIZERS
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-13.83% 24.93% 153.69% 508.93% |
56.02% 173.3% 103.81% 146.54% |
QtrlyTrend |
6 | |
Latest Qtr: Dec2024 | ||
Quarterly Result Analysis → |
KHAITAN CHEMICALS & FERTILIZERS related INDICES
You may also like the below Video Courses
FAQ about KHAITAN CHEMICALS & FERTILIZERS
Is KHAITAN CHEMICALS & FERTILIZERS good for long term investment?
As on Apr 17,2025, the Fundamentals of KHAITAN CHEMICALS & FERTILIZERS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of KHAITAN CHEMICALS & FERTILIZERS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is KHAITAN CHEMICALS & FERTILIZERS UnderValued or OverValued?
As on Apr 17,2025, KHAITAN CHEMICALS & FERTILIZERS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of KHAITAN CHEMICALS & FERTILIZERS ?
As on Apr 17,2025, the Intrinsic Value of KHAITAN CHEMICALS & FERTILIZERS is Rs. 20.46 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -51.72
Fair Value [Median EV / Sales Model] : Rs. 20.74
Fair Value [Median Price / Sales Model] : Rs. 20.18
Estimated Median Fair Value of KHAITAN CHEMICALS & FERTILIZERS : Rs. 20.46
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.